Canaccord

Canaccord Genuity on Monday downgraded Abengoa Yield PLC (NASDAQ: ABY) amid corporate structure and growth concerns. The firm now rates Abengoa as a Hold and lowered the stock's price target from $29.50 to $16. Analysts John Quealy and Chip Moore wrote, "While we find the return of ex-...

AtriCure Inc (NASDAQ: ATRC) shares have lost 19 percent in the last three months, even after hitting their 52-week high of $28.15 in August. Canaccord’s Jason Mills maintained a Buy rating on the company, with a price target of $31. Recent weakness in the company’s shares and...

Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY)'s sell-off is unrelated to data the company presented late Tuesday for its prospective hemophilia treatment, an analyst said. Deutsche Bank's Alethia Young attributed the decline to "fast money, selling," and has previously...

Kite Pharma Inc (NASDAQ: KITE) hopes to seek regulatory approval next year for a treatment for a form of lymphoma, an analyst said Wednesday. Jefferies' Biren Amin reiterated a Buy rating and $83 target following Kite executives meeting with analysts in New York Tuesday. Canaccord's...

Canaccord analyst Michael Graham recently penned the firm’s “Monthly Internet Dashboard,” a monthly analysis of the operating metrics, stock sentiment, and other quantitative factors of companies in the Internet business. The report provides the most up-to-date statistics on...

In a report published Thursday, Canaccord analyst Michael Graham maintained his Buy rating and $650 price target on Google Inc (NASDAQ: GOOG). The stock has decline about 4.5 percent over the past 12 months, as compared to the 11 percent rise in the S&P. The underperformance of Google's...

Zillow Group Inc (NASDAQ: Z) posted first quarter 2015 results on May 12. The online real estate database posted wider losses than anticipated but strong mobile growth. Much of the report reflected the Trulia acquisition; the competitor bought by Zillow in February for $2.5 billion. Zillow...

Skyworks Solutions Inc (NASDAQ: SWKS)'s semiconductors will continue to gain content share in high-end smartphones in 2015 while its growth in broader markets for connectivity should top 20 percent, an analyst said Friday. Skyworks gained about 6 percent recently to $97.75; Late Thursday,...

Canaccord downgraded Agios Pharmaceuticals Inc (NASDAQ: AGIO) Thursday from Buy to Hold and cut its price target from $163 to $103. Analysts John Newman and Kevin Dai commented, “Agios announced plans to move AG-881, a dual IDH1 and IDH2 mutation inhibitor, into glioma patients, which...

Gabriel Dechaine of Canaccord Genuity offers insight on his top-rated Canadian-based insurance companies ahead of earnings. For the overall sector, Dechaine notes that “long bond yields in the U.S. and Canada fell 20 to 35 bps. Equity markets were generally positive, with a rise in Canadian...